Search research articles
Contact Us
Filters
Showing results (61-70 of 104) with videos related to
Page
of 11
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
March 27, 2007
Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide
E Büssemaker, Frank Pistrosch, Sarah Förster, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 9, 2022
Polymorphism and optical, magnetic and thermal properties of the either phyllo- or inosilicate-analogous borosulfate Cu[B<sub>2</sub>(SO<sub>4</sub>)<sub>4</sub>]
Matthias Hämmer, Florian Pielnhofer, Oliver Janka, et al.
Thrombosis Research
|
April 19, 2021
Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey
Stephanie Carlin, Alison Bond, Peter Gross, et al.
Gastroenterology
|
April 3, 2003
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial
Alexander L Gerbes, Veit Gülberg, Pere Ginès, et al.
Current Biology : CB
|
November 18, 2023
Axis convergence in C. elegans embryos
Archit Bhatnagar, Michael Nestler, Peter Gross, et al.
Thrombosis and Haemostasis
|
December 1, 2021
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review
Ilia Makedonov, Susan R Kahn, Jameel Abdulrehman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist
Alain Soupart, Peter Gross, Jean-Jacques Legros, et al.
The New England Journal of Medicine
|
November 16, 2006
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
Robert W Schrier, Peter Gross, Mihai Gheorghiade, et al.
Experimental Gerontology
|
January 5, 2002
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
Donna M Murasko, Erica D Bernstein, Elizabeth M Gardner, et al.
The American Journal of Cardiology
|
February 17, 2016
Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation
Alan D Bell, Peter Gross, Michael Heffernan, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 104) with videos related to
Sort By:
Page
of 11
American Journal of Physiology. Heart and Circulatory Physiology
|
March 27, 2007
Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide
E Büssemaker, Frank Pistrosch, Sarah Förster, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 9, 2022
Polymorphism and optical, magnetic and thermal properties of the either phyllo- or inosilicate-analogous borosulfate Cu[B<sub>2</sub>(SO<sub>4</sub>)<sub>4</sub>]
Matthias Hämmer, Florian Pielnhofer, Oliver Janka, et al.
Thrombosis Research
|
April 19, 2021
Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey
Stephanie Carlin, Alison Bond, Peter Gross, et al.
Gastroenterology
|
April 3, 2003
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial
Alexander L Gerbes, Veit Gülberg, Pere Ginès, et al.
Current Biology : CB
|
November 18, 2023
Axis convergence in C. elegans embryos
Archit Bhatnagar, Michael Nestler, Peter Gross, et al.
Thrombosis and Haemostasis
|
December 1, 2021
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review
Ilia Makedonov, Susan R Kahn, Jameel Abdulrehman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist
Alain Soupart, Peter Gross, Jean-Jacques Legros, et al.
The New England Journal of Medicine
|
November 16, 2006
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
Robert W Schrier, Peter Gross, Mihai Gheorghiade, et al.
Experimental Gerontology
|
January 5, 2002
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
Donna M Murasko, Erica D Bernstein, Elizabeth M Gardner, et al.
The American Journal of Cardiology
|
February 17, 2016
Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation
Alan D Bell, Peter Gross, Michael Heffernan, et al.
Page
of 11